Future studies should investigative additional patients to confirm the correlation between in vitro AMD cybrid responses to Ranibizumab and clinical responses of wAMD patients to antiVEGF treatments over monthly anti-VEGF treatments. Here, VEGFA is linked to age-related macular degeneration.